Drug Approval | January 31, 2024
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Combines biocompatibility, heat-resistance, transparency and durability
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
Atlas AI combines NVIDIA BioNeMo cloud APIs for intelligent chemical and protein design
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Arco Lab now holds a 50% stake in Neviton
Sirius JV will be owned 51% by Sirius and 49% by Adani
Subscribe To Our Newsletter & Stay Updated
